{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:33:10Z","timestamp":1792045990273,"version":"4.4.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK67620"],"award-info":[{"award-number":["DK67620"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL-57853"],"award-info":[{"award-number":["HL-57853"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL-73287"],"award-info":[{"award-number":["HL-73287"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.biopha.2018.01.065","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T11:53:35Z","timestamp":1519127615000},"page":"261-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Genetic ablation of TRPV1 exacerbates pressure overload-induced cardiac hypertrophy"],"prefix":"10.1016","volume":"99","author":[{"given":"Beihua","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangtao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biopha.2018.01.065_bib0005","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.CIR.102.4.470","article-title":"Left ventricular hypertrophy: pathogenesis, detection, and prognosis","volume":"102","author":"Lorell","year":"2000","journal-title":"Circulation"},{"issue":"9507","key":"10.1016\/j.biopha.2018.01.065_bib0010","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0140-6736(06)68074-4","article-title":"Controversies in ventricular remodelling","volume":"367","author":"Opie","year":"2006","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.biopha.2018.01.065_bib0015","doi-asserted-by":"crossref","first-page":"H1712","DOI":"10.1152\/ajpheart.00124.2004","article-title":"NF-kappaB activation is required for the development of cardiac hypertrophy in vivo","volume":"287","author":"Li","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol"},{"issue":"25","key":"10.1016\/j.biopha.2018.01.065_bib0020","doi-asserted-by":"crossref","first-page":"23115","DOI":"10.1074\/jbc.M100814200","article-title":"gp130 plays a critical role in pressure overload-induced cardiac hypertrophy","volume":"276","author":"Uozumi","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.biopha.2018.01.065_bib0025","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1161\/CIRCULATIONAHA.106.643585","article-title":"Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state","volume":"115","author":"Sun","year":"2007","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.biopha.2018.01.065_bib0030","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/01.RES.81.4.627","article-title":"Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha","volume":"81","author":"Kubota","year":"1997","journal-title":"Circ. Res."},{"issue":"6653","key":"10.1016\/j.biopha.2018.01.065_bib0035","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/39807","article-title":"The capsaicin receptor: a heat-activated ion channel in the pain pathway","volume":"389","author":"Caterina","year":"1997","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.biopha.2018.01.065_bib0040","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.1073\/pnas.122196999","article-title":"An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors","volume":"99","author":"Huang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"16","key":"10.1016\/j.biopha.2018.01.065_bib0045","doi-asserted-by":"crossref","first-page":"13633","DOI":"10.1074\/jbc.M211231200","article-title":"N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia","volume":"278","author":"Chu","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2018.01.065_bib0050","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.4049\/jimmunol.172.4.2341","article-title":"Immunosuppressive activity of endovanilloids: N-arachidonoyl-dopamine inhibits activation of the NF-kappa B, NFAT, and activator protein 1 signaling pathways","volume":"172","author":"Sancho","year":"2004","journal-title":"J. Immunol. (Baltimore, Md. 1950)"},{"issue":"10","key":"10.1016\/j.biopha.2018.01.065_bib0055","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.4049\/jimmunol.157.10.4412","article-title":"Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is a potent inhibitor of nuclear transcription factor-kappa B activation by diverse agents","volume":"157","author":"Singh","year":"1996","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2018.01.065_bib0060","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1213\/01.ANE.0000132975.02854.65","article-title":"Small-dose capsaicin reduces systemic inflammatory responses in septic rats","volume":"99","author":"Demirbilek","year":"2004","journal-title":"Anesth. Analgesia"},{"issue":"4","key":"10.1016\/j.biopha.2018.01.065_bib0065","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/HCO.0b013e32830460ad","article-title":"Transient receptor potential vanilloid channels in hypertension, inflammation, and end organ damage: an imminent target of therapy for cardiovascular disease?","volume":"23","author":"Wang","year":"2008","journal-title":"Curr. Opin. Cardiol."},{"issue":"13","key":"10.1016\/j.biopha.2018.01.065_bib0070","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1096\/fj.06-7460com","article-title":"The transient receptor potential vanilloid 1 (TRPV1) receptor protects against the onset of sepsis after endotoxin","volume":"21","author":"Clark","year":"2007","journal-title":"Faseb J."},{"issue":"2","key":"10.1016\/j.biopha.2018.01.065_bib0075","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/HYPERTENSIONAHA.108.110197","article-title":"Deletion of transient receptor potential vanilloid type 1 receptors exaggerates renal damage in deoxycorticosterone acetate-salt hypertension","volume":"52","author":"Wang","year":"2008","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.biopha.2018.01.065_bib0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/HYPERTENSIONAHA.108.118349","article-title":"Transient receptor potential vanilloid gene deletion exacerbates inflammation and atypical cardiac remodeling after myocardial infarction","volume":"53","author":"Huang","year":"2009","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.biopha.2018.01.065_bib0085","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4049\/jimmunol.160.2.993","article-title":"Neuropeptides, via specific receptors, regulate T cell adhesion to fibronectin","volume":"160","author":"Levite","year":"1998","journal-title":"J. Immunol."},{"issue":"19","key":"10.1016\/j.biopha.2018.01.065_bib0090","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.2174\/092986706777935131","article-title":"Regulation of inflammatory responses by sensory neurons: molecular mechanism(s) and possible therapeutic applications","volume":"13","author":"Okajima","year":"2006","journal-title":"Curr. Med. Chem."},{"issue":"13","key":"10.1016\/j.biopha.2018.01.065_bib0095","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/01.CIR.0000142618.20278.7A","article-title":"Sensing tissue ischemia: another new function for capsaicin receptors?","volume":"110","author":"Pan","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.biopha.2018.01.065_bib0100","doi-asserted-by":"crossref","first-page":"H1791","DOI":"10.1152\/ajpheart.00169.2007","article-title":"TRPV1 gene knockout impairs preconditioning protection against myocardial injury in isolated perfused hearts in mice","volume":"293","author":"Zhong","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"23","key":"10.1016\/j.biopha.2018.01.065_bib0105","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1161\/CIRCULATIONAHA.105.556274","article-title":"TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice","volume":"112","author":"Wang","year":"2005","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.biopha.2018.01.065_bib0110","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00210-004-0985-7","article-title":"Selective sensory denervation by capsaicin aggravates adriamycin-induced cardiomyopathy in rats","volume":"370","author":"Katona","year":"2004","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.065_bib0115","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1096\/fj.05-4060fje","article-title":"Capsaicin-sensitive sensory neurons regulate myocardial function and gene expression pattern of rat hearts: a DNA microarray study","volume":"20","author":"Zvara","year":"2006","journal-title":"Faseb J."},{"issue":"3","key":"10.1016\/j.biopha.2018.01.065_bib0120","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00108.2003","article-title":"Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload","volume":"285","author":"Hu","year":"2003","journal-title":"Am. J. Physiol Heart Circ. Physiol"},{"issue":"1","key":"10.1016\/j.biopha.2018.01.065_bib0125","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0003-2697(73)90316-3","article-title":"A quick and specific assay for hydroxyproline","volume":"55","author":"Blumenkrantz","year":"1973","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.065_bib0130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1078\/0171-2985-00110","article-title":"Systemic immunosuppression fails to suppress cardiac cytokine induction in pressure overload hypertrophy in rats","volume":"205","author":"Jeron","year":"2002","journal-title":"Immunobiology"},{"issue":"6","key":"10.1016\/j.biopha.2018.01.065_bib0135","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1006\/jmcc.1994.1090","article-title":"Developmental pattern of ventricular atrial natriuretic peptide (ANP) expression in chronically hypoxic rats as an indicator of the hypertrophic process","volume":"26","author":"McKenzie","year":"1994","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.biopha.2018.01.065_bib0140","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/01.RES.81.2.187","article-title":"Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium","volume":"81","author":"Kapadia","year":"1997","journal-title":"Circ. Res."},{"issue":"20","key":"10.1016\/j.biopha.2018.01.065_bib0145","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1161\/01.CIR.0000147233.10318.23","article-title":"Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction","volume":"110","author":"Sun","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.biopha.2018.01.065_bib0150","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.neuroscience.2008.05.036","article-title":"Tumor necrosis factor alpha enhances the sensitivity of rat trigeminal neurons to capsaicin","volume":"155","author":"Khan","year":"2008","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.biopha.2018.01.065_bib0155","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1161\/01.CIR.0000057810.48709.F6","article-title":"Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the framingham heart study","volume":"107","author":"Vasan","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.biopha.2018.01.065_bib0160","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/HYPERTENSIONAHA.109.148635","article-title":"Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats","volume":"56","author":"Melendez","year":"2010","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.biopha.2018.01.065_bib0165","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/cvr\/cvq274","article-title":"Cardiomyocyte NF-kappaB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure","volume":"89","author":"Hamid","year":"2011","journal-title":"Cardiovasc. Res."},{"issue":"9","key":"10.1016\/j.biopha.2018.01.065_bib0170","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/CIRCRESAHA.110.226928","article-title":"Multiple facets of NF-kappaB in the heart: to be or not to NF-kappaB","volume":"108","author":"Gordon","year":"2011","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.biopha.2018.01.065_bib0175","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/cvr\/cvp237","article-title":"NF-kappaB activation is required for adaptive cardiac hypertrophy","volume":"84","author":"Zelarayan","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2018.01.065_bib0180","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejphar.2009.10.044","article-title":"Transient receptor potential vanilloid 1 agonists as candidates for anti-inflammatory and immunomodulatory agents","volume":"627","author":"Tsuji","year":"2010","journal-title":"Eur J. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2018.01.065_bib0185","doi-asserted-by":"crossref","first-page":"F1550","DOI":"10.1152\/ajprenal.00012.2009","article-title":"Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension","volume":"297","author":"Wang","year":"2009","journal-title":"Am. J. Physiol Ren. Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2018.01.065_bib0190","first-page":"409","article-title":"Factors and mechanisms involved in left ventricular hypertrophy and the anti-hypertrophic role of nitric oxide","volume":"90","author":"Garcia","year":"2008","journal-title":"Arq Bras Cardiol."},{"issue":"3","key":"10.1016\/j.biopha.2018.01.065_bib0195","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/01.RES.73.3.579","article-title":"Peptidergic innervation of human epicardial coronary arteries","volume":"73","author":"Gulbenkian","year":"1993","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.biopha.2018.01.065_bib0200","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1161\/01.RES.0000148633.93110.24","article-title":"Vanilloid receptor TRPV1, sensory C-fibers, and vascular autoregulation: a novel mechanism involved in myogenic constriction","volume":"95","author":"Scotland","year":"2004","journal-title":"Circ. Res."},{"issue":"5997","key":"10.1016\/j.biopha.2018.01.065_bib0205","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/313054a0","article-title":"Calcitonin gene-related peptide is a potent vasodilator","volume":"313","author":"Brain","year":"1985","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biopha.2018.01.065_bib0210","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1152\/physrev.00037.2003","article-title":"Vascular actions of calcitonin gene-related peptide and adrenomedullin","volume":"84","author":"Brain","year":"2004","journal-title":"Physiol Rev."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.065_bib0215","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/cvr\/cvn012","article-title":"A reactive oxygen species-mediated component in neurogenic vasodilatation","volume":"78","author":"Starr","year":"2008","journal-title":"Cardiovasc. Res."},{"issue":"Suppl","key":"10.1016\/j.biopha.2018.01.065_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/140174398427956","article-title":"Release and effects of calcitonin gene-related peptide in myocardial ischaemia","volume":"49","author":"Kallner","year":"1998","journal-title":"Scand. Cardiovasc. J."},{"issue":"3","key":"10.1016\/j.biopha.2018.01.065_bib0225","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00005344-199809000-00023","article-title":"Aggravation of myocardial infarction in the porcine heart by capsaicin-induced depletion of calcitonin gene-related peptide (CGRP)","volume":"32","author":"Kallner","year":"1998","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"14","key":"10.1016\/j.biopha.2018.01.065_bib0230","doi-asserted-by":"crossref","first-page":"L193","DOI":"10.1016\/0024-3205(95)02100-W","article-title":"Anti-inflammatory activity of amylin and CGRP in different experimental models of inflammation","volume":"57","author":"Clementi","year":"1995","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.biopha.2018.01.065_bib0235","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jhep.2009.03.022","article-title":"The neuropeptide calcitonin gene-related peptide (CGRP) prevents inflammatory liver injury in mice","volume":"51","author":"Kroeger","year":"2009","journal-title":"J. Hepatol"},{"issue":"1","key":"10.1016\/j.biopha.2018.01.065_bib0240","doi-asserted-by":"crossref","first-page":"L202","DOI":"10.1152\/ajplung.00064.2004","article-title":"Antiproliferative effects of calcitonin gene-related peptide in aortic and pulmonary artery smooth muscle cells","volume":"288","author":"Chattergoon","year":"2005","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"2\u20133","key":"10.1016\/j.biopha.2018.01.065_bib0245","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0167-0115(02)00100-3","article-title":"Role of calcitonin gene-related peptide (CGRP) in chronic hypoxia-induced pulmonary hypertension in the mouse. influence of gene transfer in vivo","volume":"108","author":"Bivalacqua","year":"2002","journal-title":"Regul. Pept"},{"issue":"2","key":"10.1016\/j.biopha.2018.01.065_bib0250","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/01.HYP.0000254415.31362.a7","article-title":"Role of oxidative stress in cardiac hypertrophy and remodeling","volume":"49","author":"Takimoto","year":"2007","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.biopha.2018.01.065_bib0255","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.atherosclerosis.2010.08.050","article-title":"Calcitonin gene-related peptide inhibits angiotensin II-induced endothelial progenitor cells senescence through up-regulation of klotho expression","volume":"213","author":"Zhou","year":"2010","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.biopha.2018.01.065_bib0260","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/oxfordjournals.eurheartj.a014742","article-title":"Diastolic dysfunction and ANP\/BNP levels","volume":"17","author":"Struthers","year":"1996","journal-title":"Eur Heart J."},{"issue":"4","key":"10.1016\/j.biopha.2018.01.065_bib0265","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/heart.87.4.314","article-title":"Natriuretic peptide receptors and the heart","volume":"87","author":"King","year":"2002","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.biopha.2018.01.065_bib0270","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1073\/pnas.85.2.339","article-title":"Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload","volume":"85","author":"Izumo","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"3","key":"10.1016\/j.biopha.2018.01.065_bib0275","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3317\/jraas.2004.028","article-title":"BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction","volume":"5","author":"Falcao","year":"2004","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"issue":"2","key":"10.1016\/j.biopha.2018.01.065_bib0280","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.HYP.25.2.227","article-title":"Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts","volume":"25","author":"Cao","year":"1995","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.biopha.2018.01.065_bib0285","doi-asserted-by":"crossref","first-page":"H707","DOI":"10.1152\/ajpheart.00677.2001","article-title":"Ventricular expression of natriuretic peptides in Npr1(-\/-) mice with cardiac hypertrophy and fibrosis","volume":"283","author":"Ellmers","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2018.01.065_bib0290","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.RES.51.6.787","article-title":"Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines","volume":"51","author":"Simpson","year":"1982","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.065_bib0295","doi-asserted-by":"crossref","DOI":"10.1161\/01.RES.69.1.209","article-title":"Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes","volume":"69","author":"Ito","year":"1991","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.biopha.2018.01.065_bib0300","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/01.RES.73.3.413","article-title":"Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. critical role of the AT1 receptor subtype","volume":"73","author":"Sadoshima","year":"1993","journal-title":"Circ. Res."},{"issue":"16","key":"10.1016\/j.biopha.2018.01.065_bib0305","doi-asserted-by":"crossref","first-page":"9535","DOI":"10.1074\/jbc.271.16.9535","article-title":"Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130\/leukemia inhibitory factor receptor-dependent pathways","volume":"271","author":"Wollert","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2018.01.065_bib0310","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1172\/JCI117706","article-title":"Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure","volume":"95","author":"Duerr","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.biopha.2018.01.065_bib0315","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.phrs.2009.11.012","article-title":"Molecular targets and regulators of cardiac hypertrophy","volume":"61","author":"Rohini","year":"2010","journal-title":"Pharmacol. Res."},{"issue":"11","key":"10.1016\/j.biopha.2018.01.065_bib0320","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1006\/jmcc.1999.1030","article-title":"Effect of interleukin-1 beta on cardiac hypertrophy and production of natriuretic peptides in rat cardiocyte culture","volume":"31","author":"Harada","year":"1999","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2\u20133","key":"10.1016\/j.biopha.2018.01.065_bib0325","first-page":"80","article-title":"ANP expression in the hypertensive heart","volume":"7","author":"Kessler-Icekson","year":"2002","journal-title":"Exp. Clin. Cardiol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221735062X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221735062X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:23:50Z","timestamp":1781591030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333221735062X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":65,"alternative-id":["S075333221735062X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.01.065","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic ablation of TRPV1 exacerbates pressure overload-induced cardiac hypertrophy","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.01.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}